[Tuberculous lymphadenitis after successful treatment of hepatitis C]

MeSH terms

• Adult
• Antiviral Agents / adverse effects*
• Antiviral Agents / therapeutic use
• Cytokines / biosynthesis
• Hepatitis C, Chronic / complications
• Hepatitis C, Chronic / drug therapy*
• Humans
• Immunocompromised Host
• Interferon-alpha / adverse effects*
• Interferon-alpha / therapeutic use
• Latent Tuberculosis / complications*
• Male
• Mycobacterium tuberculosis / growth & development
• Mycobacterium tuberculosis / physiology
• Opportunistic Infections / etiology*
• Pakistan / epidemiology
• Polyethylene Glycols / adverse effects*
• Polyethylene Glycols / therapeutic use
• Recombinant Proteins / adverse effects
• Recombinant Proteins / therapeutic use
• Ribavirin / administration & dosage
• Ribavirin / therapeutic use
• Tuberculosis, Lymph Node / etiology*